Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
about
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Cannabinoids as therapeutic agents in cancer: current status and future implicationsN-Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leadsThe endocannabinoid system: directing eating behavior and macronutrient metabolismPhysical activity and the endocannabinoid system: an overviewDocosahexaenoic acid-induced apoptosis is mediated by activation of mitogen-activated protein kinases in human cancer cellsThe endocannabinoid system and cancer: therapeutic implication.Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.Prognosis of treatment response (pathological complete response) in breast cancer.5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cellsFish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissuesProgramming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitisAssociation between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study.Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury.The endocannabinoid system and sex steroid hormone-dependent cancers.Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs.The endocannabinoid system in prostate cancer.Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolismSynaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function.PUFA-derived endocannabinoids: an overview.Modulation of T-type calcium channels by bioactive lipids.Endocannabinoid signaling and its regulation by nutrients.Endocannabinoids, related compounds and their metabolic routes.The evolving role of the endocannabinoid system in gynaecological cancer.The Endocannabinoid System and its Modulation by Phytocannabinoids.Peroxisomal ATP-binding cassette transporters form mainly tetramers.Proapoptotic effect of endocannabinoids in prostate cancer cellsArachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides.Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophagesCannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years.Analysis of Omega-3 Fatty Acid Derived N-Acylethanolamines in Biological Matrices.Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition.Dietary DHA reduces downstream endocannabinoid and inflammatory gene expression and epididymal fat mass while improving aspects of glucose use in muscle in C57BL/6J mice.Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases.Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.Anti-inflammatory ω-3 endocannabinoid epoxides.
P2860
Q21132308-333FB0FA-8944-44F7-95EF-1B37F6B26835Q26866298-B532067F-1399-43AD-8ECF-6588B5E86926Q27011679-C3188A1A-187F-4CD7-9828-6087CDFF8955Q28086830-2CFC3B03-AE5E-4240-8024-2790A0E7EBD2Q28307668-E7C88357-3FF2-4AF4-A28F-427A1C3990E2Q33889524-6967991D-9992-4151-9F99-59A843621077Q35193299-8FC09E45-AAFC-4026-B184-9FBE4CD8DC83Q35871872-7B1EFF59-2026-4339-8B1D-DA230391D0F3Q35971135-21A31A72-6038-4D54-A5B7-F1A95983ACD5Q36076364-E31673D1-FF9D-46CF-9430-E62C8B8FBD71Q36353394-B9B6461C-9AF6-4139-8A98-C2F67BBF9261Q36612284-DFCA436D-5FB5-403B-9F20-6A9A8FD90727Q36620178-ACE05EBE-597F-48B3-9695-BF43C0009AB1Q36784020-1F0C2762-87CE-48CA-AFAA-F43FD8BDEE31Q37034806-146DF2D4-9B18-4CE6-9DF2-E76AAE433A88Q37351188-D3177E86-EB2D-4FFD-BD7C-637DB4D2CF23Q37393042-58E4F315-D5E3-466B-BD33-53147731DDD4Q37716381-6CD15EC0-0A63-4C42-9220-1168DE1427F2Q37930973-7604DBB8-FB66-4AFC-9441-6E6D3700ADB7Q37988008-EAE07237-8937-4B06-9628-E9B24C57563DQ38041843-BAB91DBC-1DB6-4379-9A92-1CF32577E654Q38135917-76BD1EAE-A3F4-49EA-91A4-283118E4FD7FQ38188442-C156A86D-DE1C-4F2E-A983-D337FCE8E768Q38206187-04A72E27-9B3C-4C52-8198-974279803429Q38262964-68ADCD4B-FCE3-480E-BE78-8D0F796E9FA8Q38469671-50ECD1E7-7F70-4D22-A8F5-26B45C134E71Q38566339-00B49D33-657A-4451-AE32-B4D61608F392Q38713957-EC44B3D2-A96B-4FCF-96DC-042C1EE754B4Q38918051-9F64AEB1-FC23-4CB8-A8FB-DCD30E0944B3Q38923372-72FFA92D-E473-4F93-9636-AC8F0A9E0529Q38964675-F897CE72-0A08-4701-9943-CCB272FAEFAAQ39000393-293E504D-997F-4C90-A0BD-960457FA6FD3Q39021787-DC86AC96-19FB-457F-99F4-11ABFE9F43ADQ39370805-847DD0FB-14D0-4F49-BB5D-22D06DC7EB50Q39721348-ADE0A27C-1795-4917-8392-855941A3683FQ40066269-B465A0F1-5542-4B81-8D33-BE954C89A82AQ42108312-70DFFD5F-C343-4E71-97F2-796BFC962C15Q47148039-8C282251-322E-4301-8A8D-82D9AB87C72EQ47818880-0B5E1322-79AD-44CA-ADB1-D3D1C67FA0ADQ47948005-8C886BF1-B514-463E-82B5-302BB47C1B60
P2860
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@ast
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@en
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@nl
type
label
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@ast
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@en
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@nl
prefLabel
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@ast
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@en
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@nl
P2093
P2860
P921
P356
P1433
P1476
Cannabinoid receptor-dependent ...... ive prostate cancer cell lines
@en
P2093
Iain Brown
Klaus W J Wahle
Maria G Cascio
Reem Smoum
Roger G Pertwee
Ruth A Ross
Steven D Heys
P2860
P304
P356
10.1093/CARCIN/BGQ151
P407
P577
2010-07-25T00:00:00Z